Biomea Fusion, Inc. (BMEA) vs ImmuCell Corporation (ICCC)
A side-by-side comparison of Biomea Fusion, Inc. and ImmuCell Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BMEA
Biomea Fusion, Inc.
$1.25HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
ICCC
ImmuCell Corporation
$9.99HealthcareDelayed quote: Oct 6, 2026, 10:34 AM EDT
Total return — BMEA vs ICCC
growth of $100 · dividends reinvested · last 5yBMEA -92.4% (-40.2%/yr)ICCC +8.6% (+1.7%/yr)ICCC compounded faster over this window
Log scale — wide-divergence pair
BMEA ICCC
BMEA vs ICCC: by the numbers
- •ICCC is the larger company ($90M vs $90M market cap).
- •ICCC is profitable (2.57% net margin) while BMEA runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | BMEA | ICCC |
|---|---|---|
| P/E ratio | N/A | 118.09 |
| P/S ratio | N/A | 2.95 |
| P/B ratio | 7.45 | 2.88 |
| EV / EBITDA | N/A | 15.03 |
| FCF yield | N/A | 4.66% |
Profitability
| Metric | BMEA | ICCC |
|---|---|---|
| Gross margin | 0.00% | 40.32% |
| Operating margin | 0.00% | 12.60% |
| Net margin | 0.00% | 2.57% |
| ROE | -268.09% | 2.51% |
| ROIC | -220.02% | 8.16% |
Growth (annualized)
| Metric | BMEA | ICCC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 13.74% |
| Total return CAGR (5Y) | -36.56% | 0.65% |
Frequently asked
- Is BMEA or ICCC more profitable?
- ICCC runs the higher net margin — BMEA at 0.00% versus ICCC at 2.57%.
- How have BMEA and ICCC total returns compared?
- Over the past 5 years, BMEA delivered -36.56% and ICCC delivered 0.65% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ImmuCell P/E ratioBiomea Fusion ROEImmuCell ROEBiomea Fusion operating marginImmuCell operating marginBiomea Fusion revenue growthImmuCell revenue growthBiomea Fusion free cash flowImmuCell free cash flow
Biomea Fusion & ImmuCell appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.